On behalf of Vice President, Prime Minister and Ruler of Dubai, His Highness Sheikh Mohammed bin Rashid Al Maktoum, Princess Haya bint Al Hussein, Chairperson of Dubai Healthcare City Authority and wife of Sheikh Mohammed, inaugurated Mediclinic City Hospital’s new Comprehensive Cancer Centre, CCC, Dubai’s most advanced facility for the diagnosis and treatment of cancer.
As part of the inauguration, Princess Haya toured the centre, alongside Maya Tissafi, Ambassador of Switzerland to the UAE; David Hadley, CEO of Mediclinic Middle East; Dr. Tarek Fathey, COO; Ahmed Ali, Executive Director and Christian Schuhmacher, Director of Mediclinic City Hospital. Also in attendance were Dr. Raja Easa Al Gurg, Deputy Chairperson of the Board of Directors, DHCA; Khalid Al Shamsi, Representative of the Chairperson of DHCA; Dr. Amer Al Zarooni, CEO DHCM; Dr. Ramadan Al Balooshi, CEO DHCR; Bader Hareb, CEO DHCC; Dr. Alawi Alsheikh Ali, Dean of College of Medicine, MBRU; Professor Sehamuddin Galadari, Al Jalila Foundation and Professor Mutairu Ezimokhai, Provost MBRU of Medicine and Health Sciences.
During the tour, Princess Haya visited the Radiotherapy Department, which is equipped with the UAE’s first TrueBeam linear accelerator for radiation therapy, which offers oncology patients the very latest in treatment technology. She also viewed the centre’s diagnostic capabilities in the Nuclear Medicine Department.
Princess Haya also took the time to visit a paediatric and an adult patient, both of whom are currently receiving chemotherapy treatment at the centre. She was lastly introduced to the centre’s Hospital Angels programme, a voluntary scheme to empower individuals and the community to engage in the charitable act of caring for those most in need, as well as to contribute to improving the nation’s health, in line with the direction from the leaders of the UAE.
HRH Princess Haya also spoke with Dr. Shaheenah Dawood, Consultant Oncologist, about ongoing research in oncology studies, and the recently awarded Jalila Foundation Research Centre, which will enable further research in the field of oncology in the country.
Built in collaboration with Mediclinic Middle East’s sister platform in Switzerland, Hirslanden, patients at the CCC will benefit from the sharing of knowledge and experience between some of the leading oncology experts in Europe and the Middle East, as well as have access to the latest treatment programmes and technologies, which will enable patients to receive their diagnosis and treatment in the UAE, without travelling overseas.